Possible role of low-dose etoposide therapy for hemophagocytic lymphohistiocytosis by COVID-19
Possible role of low-dose etoposide therapy for hemophagocytic lymphohistiocytosis by COVID-19
About this item
Full title
Possible role of low-dose etoposide therapy for hemophagocytic lymphohistiocytosis by COVID-19
Author / Creator
Publisher
Singapore: Springer Singapore
Journal title
International journal of hematology, 2020-07, Vol.112 (1), p.122-124
Language
English
Formats
Publication information
Publisher
Singapore: Springer Singapore
Subjects
More information
Alternative Titles
Full title
Possible role of low-dose etoposide therapy for hemophagocytic lymphohistiocytosis by COVID-19
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7216850
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7216850
Other Identifiers
ISSN
0925-5710
E-ISSN
1865-3774
DOI
10.1007/s12185-020-02888-9
